Blog & News

We have a few things to say about prescription savings.
Article

Star Wars and Medicine Today

As with medicine today one of the major and newer technologies is robotic surgery and robotic assist. Surgical robots, such as the da Vinci surgical system, allow surgeons to perform with greater precision and require smaller incisions. In a robotic surgery, the surgeon controls robotic arms with a remote manipulator or a computer. Common robot-assisted surgeries include prostate cancer tumor removal and bariatric surgery.

Read More »
News

Castlight Health and RazorMetrics Join Forces

AUSTIN, Texas, April 26, 2022/PRNewswire/ – Castlight Health is the newest member of RazorMetrics’ Partnership Collective, and RazorMetrics is joining Castlight’s Ecosystem of leading digital health companies. Castlight, a connected health navigation company, offers a world-class digital platform with a team of clinical and benefits experts who help members easily connect with the right programs and care at the right time, delivering better health outcomes and helping to maximize returns on healthcare investments.

Read More »
Press

Navigating High Drug Costs: Study Finds Consumers Want Their Physician to Lead

RazorMetrics, an innovative healthcare technology company, recently conducted a consumer opinion survey asking about drug costs and found some surprising results. Despite the explosion in consumer-oriented drug savings options – mail-order pharmacy, discount cards, etc. – healthcare consumers want their physician to take the lead on lowering drug costs. The survey found that 80% of respondents would prefer their physician be the one to choose a lower-cost drug for their prescription and do so automatically.

Read More »
Article

Could Drug Recalls Be Handled Better? Definitely.

Last week, Pfizer voluntarily recalled three of their hypertension drugs, including Accuretic, due to nitrosamine levels in the medication. Nitrosamine is common and safe in low amounts, but the drug pushed people above the acceptable daily intake limit, which increased the risk of cancer down the road.

Read More »
Article

Health Tech Tackling Rising Drug Costs, Not Congress

In a recent article in Yahoo Finance, ‘As President Biden eyes drug pricing, expert laments ‘failure of democracy’.  The article states that 25% of Americans can’t afford their prescriptions and one-third have skipped a prescription due to cost.

Read More »
Article

Pharmacist Renaissance 

Pharmacists have been a godsend to many people looking for healthcare during COVID as they stepped up during the pandemic to offer COVID testing and vaccinations, a departure from traditional healthcare delivery. It’s paid off. As of Jan. 12, retail pharmacies participating in the Federal Retail Pharmacy Program have administered more than 215.9 million doses.

Read More »
Article

The Secret behind RazorMetrics? A Great Partnership

Co-founders Siva Mohan and Tom Dorsett come from very different backgrounds; one is a talented cardiologist and the other a successful entrepreneur. What they share is an “abiding optimism”, complete faith that there are no unsolvable problems.

Read More »

RazorMetrics Launches Partnership Collective

The Partnership Collective is comprised of tightly integrated health technology companies with a common goal: drug cost containment and reduction.

Partners in the Collective are benefit management platforms and other types of application providers that count large employers and health plans as clients. RazorMetrics has launched the new initiative to integrate its solution into partners’ technology to seamlessly add drug-cost savings to their existing offerings. Access to the collective will help benefit providers attract new clients and retain current ones by offering a more competitive benefit.

Read More »

Sopris Capital Leads $6,000,000 Series A Investment in RazorMetrics

Sopris Capital, a leading healthcare investment firm, is entering the drug cost transparency space with a new partnership with RazorMetrics, a rapidly growing healthcare technology company focused on lowering pharmacy costs for at-risk employers and health plans. The Series A investment of $6,000,000 was led by Sopris and other individual investors including long-term entrepreneurs Joel Trammell and Jonathan Weiner.

Read More »

Ready to Get Started?

We're Here

To Help You Save

And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.